NSABP Foundation, Inc
Pittsburgh, Pennsylvania, United States
Research foundation in Pittsburgh, Pennsylvania
2 # 1200, Allegheny Square E, Pittsburgh, PA 15212
About NSABP Foundation, Inc
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
NSABP Foundation Inc
9
Eli Lilly and Company
1
German Breast Group
1
Clinical Trials at NSABP Foundation, Inc
During the past decade, NSABP Foundation, Inc conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on
average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer
2006-08-01
2009-11-01
Completed
45
A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer
2001-11-01
2005-11-01
Completed
76
Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer
2007-05-01
2014-05-01
Completed
105
A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
2007-07-01
2017-03-01
Unknown status
529
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
2008-04-01
2014-07-01
Terminated
3,509
A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver
2010-01-01
2014-11-01
Completed
20
Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer
2010-10-01
2016-11-25
Completed
141
Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer
2011-05-01
2014-03-01
Completed
21
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "NSABP Foundation, Inc"
#1 collaborator was "Genentech, Inc." with 3 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "International Drug Development Institute" with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator and "Pfizer" with 2 trials as a collaborator. Other collaborators include 2 different institutions and companies that were
collaborators in the rest 12 trials.
Clinical Trials Conditions at NSABP Foundation, Inc
According to Clinical.Site data, the most researched conditions in "NSABP Foundation, Inc" are
"Breast Cancer" (9 trials), "CPS-EG Score" (1 trials), "HER2-negative Breast Cancer" (1 trials), "Her2-normal" (1 trials) and "Hormonreceptor Positive" (1 trials). Many other conditions were trialed in "NSABP Foundation, Inc" in a lesser frequency.
Clinical Trials Intervention Types at NSABP Foundation, Inc
Most popular intervention types in "NSABP Foundation, Inc" are "Drug" (11 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (5 trials), "Bevacizumab" (3 trials), "Docetaxel" (3 trials), "Doxorubicin" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.
Clinical Trials Genders at NSABP Foundation, Inc
The vast majority of trials in "NSABP Foundation, Inc" are
9 trials for "Female" genders and 2 trials for "All" genders.
Clinical Trials Status at NSABP Foundation, Inc
Currently, there are NaN active trials in "NSABP Foundation, Inc".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in NSABP Foundation, Inc,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in NSABP Foundation, Inc, 1 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".